Home › Compare › HGHAF vs ABBV
HGHAF yields 340.32% · ABBV yields 3.06%● Live data
📍 HGHAF pulled ahead of the other in Year 1
Combined, HGHAF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HGHAF + ABBV for your $10,000?
High Arctic Energy Services Inc., an oilfield services company, provides oilfield services to exploration and production companies in Canada and Papua New Guinea. The company operates through three segments: Drilling Services, Production Services, and Ancillary Services. It offers snubbing services, including foothills standalone snubbing system for completions and workovers; hydraulic workover units, such as a patented L-Frame equipment configuration; rig assist snubbing unit, a truck-mounted hydraulic system to manage underbalanced wellbore conditions; and power tower to install a snubbing unit and blowout preventers in one lift. The company also rents oilfield equipment comprising accumulators, blowout preventers, casing cutters and scrappers, hydraulic catwalks, rig shacks, chokes, boilers, boiler blowdown tanks, generators, light towers, cross over and rotary subs, elevators, EUE collars, fire suppression kits, fuel tank skids, hot tap kits, mud cans, pickers, pipe racks, power swivels, pumps, slips, spools, flanges, thread washers, tongs, trailers and accommodations, tubing, gate, plug, hydraulic/air actuated, and safety valves; and kelly cocks for drilling, completions, workover, and abandonment of oil and gas operations. In addition, it provides nitrogen pumping units; and well servicing. Further, the company owns and operates two heli-portable drilling rigs in Papua New Guinea; and offers support equipment, such as rig matting, crawler cranes, water pumps, forklifts/wheel loaders, telehandlers, lighting towers, camps, trucks, wash-down packages, vehicles, and drill pipes and BHA. High Arctic Energy Services Inc. was founded in 1993 and is headquartered in Calgary, Canada.
Full HGHAF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.